SCHEMBL6420399

SCHEMBL6420399

CC(C)(C)NC(=O)c1ccc(C(F)(F)F)cc1F

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.52
FEN1 P39748 2/20 0.52
POLB P06746 1/20 0.51
APEX1 P27695 1/20 0.51
GAA P10253 1/20 0.51
KDM4E B2RXH2 1/20 0.51
HTT P42858 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
NTRK1 P04629 3/20 0.50
NTRK2 Q16620 1/20 0.48
GPR27 Q9NS67 1/20 0.47
CFTR P13569 1/20 0.45
CES2 O00748 1/20 0.45
TRPV1 Q8NER1 1/20 0.45
SLC6A9 P48067 1/20 0.45
ANO1 Q5XXA6 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TRPV4 Q9HBA0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13407781 0.83 KDM4E (0.64) POLBGAAKDM4EHTTRXFP1
SCHEMBL8542238 0.83 CFTR (0.63) ALOX5APFEN1POLBAPEX1KDM4E
SCHEMBL6419619 0.81 POLB (0.56) ALOX5APFEN1POLBAPEX1GAA
SCHEMBL12121090 0.80 POLB (0.54) ALOX5APFEN1POLBAPEX1KDM4E
SCHEMBL26057003 0.80 GAA (0.56) GAAKDM4EHTTRXFP1NTRK1
SCHEMBL13761344 0.79 NPSR1 (0.57) GAAKDM4EHTTRXFP1NTRK1
SCHEMBL13752999 0.79 PPARD (0.50) GAAKDM4EHTTRXFP1NTRK1
SCHEMBL8547114 0.79 FLT1 (0.59) TRPV4
SCHEMBL506513 0.79 DGAT1 (0.54) POLBAPEX1GAAKDM4EHTT
SCHEMBL6415657 0.79 POLB (0.61) POLBAPEX1GAAHTTGPR27

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936736-B2 Amide derivative SUMITOMO MANUFACTURING COMPANY LIMITED (JP) 2005-08-30 US disclosed
US-20020147204-A1 Amide derivative SUMITOMO PHARMACEUTICALS COMPANY, LIMITED 2002-10-10 US disclosed
US-6384033-B1 DRUGS FOR VISION DEFECTS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2002-05-07 US disclosed
EP-1034783-A1 AMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2000-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147204-A1 Amide derivative ALDH1A2, NR1H2, HDAC3 ALOX5AP 1910/4885FEN1 4213/4885POLB 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.